Regulatory Intelligence Framework for Cell and Gene Therapies
Clarivate’s contribution as a data partner was instrumental in the development of the ISCT 2025 Cell and Gene Therapy Global Regulatory Report, providing robust, high-quality datasets that underpinned the analysis of global pipelines, regulatory activity, and market trends.
-Fajar Dumadi, BSc, Regulatory Program Specialist, International Society for Cell & Gene Therapy (ISCT)
Cell and gene therapy innovation is accelerating — but regulatory complexity is growing just as fast. Without a unified view across clinical pipelines, approvals, and evolving frameworks, it’s difficult to plan with confidence.
Discover how Clarivate helped the International Society for Cell & Gene Therapy (ISCT) create a comprehensive, data‑driven regulatory intelligence framework to guide smarter, faster decisions in a rapidly evolving landscape and:
- Enhance regulatory strategy to incorporate adaptive trial designs and innovative pathways more effectively, and align development programs with multi-regional requirements from the outset
- Develop risk identification and migration to identify access risks and strengthen evidence generation and lifecycle planning strategies
- Provide a benchmark of regulatory and clinical activity and innovation trends
